Risk Factors Subseq Invasive Bca



ABSTRACT: Risk Factors for Subsequent Invasive Breast Cancer and Breast Cancer Death after Ductal Carcinoma in Situ

In a case-control study derived from a cohort of 4661 women with a primary carcinoma in situ of the breast, we investigated age at diagnosis, mode of detection, tumor characteristics, and primary therapy, as prognostic factors for developing invasive breast cancer or dying from breast cancer.

From all of the women with a primary carcinoma in situ reported to the Swedish Cancer Registry from 1960 through 1992, we selected as cases all of the women with a ductal carcinoma in situ who later died of breast cancer (n = 39) or who developed a subsequent invasive cancer in either breast (n = 118). From this cohort, we also selected controls matched to the cases by year of diagnosis and health care region. We conducted univariate and multivariate analyses to study the association between risk of invasive cancer or death and the different risk factors.

Large size, diameter 25 mm [odds ratio (OR), 3.5; 95% confidence interval (CI), 1.1-11.4] and multifocality (OR, 3.9; 95% CI, 1.2-12.7) increased the risk of breast cancer death in univariate analysis.

Postoperative radiotherapy (OR, 0.1; 95% CI, 0.0-1.0) and mastectomy (OR, 0.1-95% CI, 0.0-0.5) lowered the risk of an ipsilateral invasive cancer in multivariate analysis.

The risk pattern by treatment category differed between those who had an ipsilateral invasive cancer and those who either had a contralateral cancer or died from breast cancer.

The driving forces behind local and generalized disease may differ. Because confounding by indication may influence the effects of different treatments, the results should be interpreted with caution.

[05/18/2001; Cancer Epidemiology, Biomarkers and Prevention]


New Concept on Disease Progression

Am J of Clinical Pathology, May 2001

Patient Perspective

Barbara H.

DCIS with Stage 1 Improved Prognosis

Braz J Med Biol Res, 8/02

Occult Axillary Micromets:DCIS

Cancer, 11/03

Risk of Contralateral BCa w/DCIS or LCIS

The Breast, 12/03 St. Gallen Intl Conf on Breast Cancer

Grade Recurrent In Situ/Invasiv Ca After DCIS

Br J Cancer, 3/04

Ctr for Medical Consumers

LINK to 2nd Opinion Pathology for DCIS (two articles)

Young Women w/DCIS not more likely to Recur

50th Annual Meeting of Am Soc of Therapeutic Radiology & Oncology (ASTRO), September 2008


Remember we are NOT Doctors and have NO medical training.

This site is like an Encyclopedia - there are many pages, many links on many topics.

Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM.